Ritodrine

CHEMBL83063 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
287.4 g/mol
LogP
2.3
Phase
4

A beta-2 adrenergic agonist used to delay premature labor by relaxing the uterine smooth muscle, giving more time for fetal lung maturation or transfer to a specialized care facility. Its use has largely been replaced by other tocolytic agents due to cardiovascular side effects.

Moleküler Ağırlık

287,3500 g/mol

LogP

2,30

TPSA

72,70 Ų

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1

InChI

InChI=1S/C17H21NO3/c1-12(17(21)14-4-8-16(20)9-5-14)18-11-10-13-2-6-15(19)7-3-13/h2-9,12,17-21H,10-11H2,1H3

Molecular Formula

C17H21NO3

HBD / HBA

4 / 4

Döndürülebilir Bağlar

6

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A beta-2 adrenergic agonist used to delay premature labor by relaxing the uterine smooth muscle, giving more time for fetal lung maturation or transfer to a specialized care facility. Its use has largely been replaced by other tocolytic agents due to cardiovascular side effects.

Yes, Ritodrine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL83063. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 33572. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.